Methods of using lactic acid bacteria as probiotic strains
Useful probiotics have been selected among lactic acid bacteria strains of the genus L. acidophilus, L. crispatus, L. gasseri, L. helveticus and L. jensenii for their ability to kill urogenital and/or gastrointestinal pathogens and their ability to inhibit internalization of urogenital and/or gastrointestinal pathogens within urogenital and/or gastrointestinal epithelial cells in humans. Probiotic compositions comprise at least one of the said lactic acid bacteria strains in combination with a suitable delivery system, such as a food product or a beverage, a food or beverage compositions, a food or beverage supplement or adjuvant.
1. A method of establishing, maintaining or restoring a healthy urogenital flora and environment in a female or a healthy gastrointestinal flora or environment in a human comprising administering to said female or said human a probiotic composition comprising an effective amount of at least one probiotic strain of the genus L. crispatus, L. gasseri, L. helveticus and L. jensenii selected from the group consisting of L. crispatus KS 116.1 (CNCM I-3483), L. crispatus KS 119.4 (CNCM I-3484), L. crispatus 127.1 (CNCM I-3486), L. gasseri KS 114.1 (CNCM I-3482), L. gasseri KS 120.1 (CNCM I-3218), L. gasseri KS 123.1 (CNCM I-3485), L. gasseri KS 124.3 (CNCM I-3220), L. helveticus KS 300 (CNCM I-3360), L. jensenii KS 119.1 (CNCM I-3217) and L. jensenii KS 121.1 (CNCM I-3219).
2. The method of claim 1 , wherein the probiotic composition comprises a mixture of Lactobacillus strains, the mixture comprising L. gasseri KS 120.1 (CNCM 1-3218) in combination with at least one of L. jensenii KS 119.1 (CNCM I-3217), L. crispatus KS 119.4 (CNCM I-3484), and L. jensenii KS 121.1 (CNCM I-3219).
3. The method according to claim 1 , wherein the at least one probiotic strain is administered in combination with a delivery system that keeps intact all the properties of the at least one probiotic strain.
4. The method according to claim 1 , wherein the probiotic composition is administered in combination with a support or carrier.
5. The method according to claim 4 , wherein the support or carrier is designed for local administration, selected from the group consisting of intra-urethral, vaginal and anal administration.
6. The method according to claim 4 wherein the support or carrier is designed for oral administration.
7. The method according to claim 6 wherein the support or carrier is a food product or a beverage, a food or beverage composition, a food or beverage supplement or adjuvant dedicated to human consumption.
8. The method according to claim 1 , wherein the probiotic composition further comprises lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients.
9. The method according to claim 8 , wherein the lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients is/are selected from the group consisting of skim milk powder (MSK), pH stabilizers, viscosity stabilizers, preservatives, antioxidants, colorants, flavors and one or more sugar(s) that match sugar metabolism profiles of the at least one probiotic strain.
10. A method of treating a urogenital infection in a female or a gastrointestinal dysbiosis and/or infection in a human comprising administering to said female or said human a probiotic composition comprising an effective amount of at least one probiotic strain of the genus L. crispatus, L. gasseri, L. helveticus and L. jensenii selected from the group consisting of L. crispatus KS 116.1 (CNCM I-3483), L. crispatus KS 119.4 (CNCM 1-3484), L. crispatus 127.1 (CNCM 1-3486), L. gasseri KS 114.1 (CNCM 1-3482), L. gasseri KS 120.1 (CNCM 1-3218), L. gasseri KS 123.1 (CNCM I-3485), L. gasseri KS 124.3 (CNCM 1-3220), L. helveticus KS 300 (CNCM 1-3360), L. jensenii KS 119.1 (CNCM 1-3217) and L. jensenii KS 121.1 (CNCM 1-3219).
11. The method of claim 10 , wherein the probiotic composition comprises a mixture of Lactobacillus strains, the mixture comprising L. gasseri KS 120.1 (CNCM 1-3218) in combination with at least one of L. jensenii KS 119.1 (CNCM I-3217), L. crispatus KS 119.4 (CNCM I-3484), and L. jensenii KS 121.1 (CNCM I-3219).
12. The method according to claim 10 , wherein the at least one probiotic strain is administered in combination with a delivery system that keeps intact all the properties of the at least one probiotic strain.
13. The method according to claim 10 , wherein the probiotic composition is administered in combination with a support or carrier.
14. The method according to claim 13 , wherein the support or carrier is designed for local administration, selected from the group consisting of intra-urethral, vaginal and anal administration.
15. The method according to claim 13 wherein the support or carrier is designed for oral administration.
16. The method according to claim 15 wherein the support or carrier is a food product or a beverage, a food or beverage composition, a food or beverage supplement or adjuvant dedicated to human consumption.
17. The method according to claim 10 , wherein the probiotic composition further comprises lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients.
18. The method according to claim 17 , wherein the lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients is/are selected from the group consisting of skim milk powder (MSK), pH stabilizers, viscosity stabilizers, preservatives, antioxidants, colorants, flavors and one or more sugar(s) that match sugar metabolism profiles of the at least one probiotic strain.
19. A method of treating an inflammatory syndrome, an infectious syndrome or a neoplasic process in a human comprising administering to said human a probiotic composition comprising an effective amount of at least one probiotic strain of the genus L. crispatus, L. gasseri, L. helveticus and L. jensenii selected from the group consisting of L. crispatus KS 116.1 (CNCM I-3483), L. crispatus KS 119.4 (CNCM 1-3484), L. crispatus 127.1 (CNCM 1-3486), L. gasseri KS 114.1 (CNCM 1-3482), L. gasseri KS 120.1 (CNCM 1-3218), L. gasseri KS 123.1 (CNCM I-3485), L. gasseri KS 124.3 (CNCM 1-3220), L. helveticus KS 300 (CNCM 1-3360), L. jensenii KS 119.1 (CNCM 1-3217) and L. jensenii KS 121.1 (CNCM I-3219).
20. The method of claim 19 , wherein the probiotic composition comprises a mixture of Lactobacillus strains, the mixture comprising L. gasseri KS 120.1 (CNCM 1-3218) in combination with at least one of L. jensenii KS 119.1 (CNCM I-3217), L. crispatus KS 119.4 (CNCM I-3484), and L. jensenii KS 121.1 (CNCM I-3219).
21. The method according to claim 19 , wherein the at least one probiotic strain is administered in combination with a delivery system that keeps intact all the properties of the at least one probiotic strain.
22. The method according to claim 19 , wherein the probiotic composition is administered in combination with a support or carrier.
23. The method according to claim 22 , wherein the support or carrier is designed for local administration, selected from the group consisting of intra-urethral, vaginal and anal administration.
24. The method according to claim 22 wherein the support or carrier is designed for oral administration.
25. The method according to claim 24 wherein the support or carrier is a food product or a beverage, a food or beverage composition, a food or beverage supplement or adjuvant dedicated to human consumption.
26. The method according to claim 19 , wherein the probiotic composition further comprises lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients.
27. The method according to claim 26 , wherein the lactic acid bacteria (LAB) growth factors and/or prebiotic ingredients is/are selected from the group consisting of skim milk powder (MSK), pH stabilizers, viscosity stabilizers, preservatives, antioxidants, colorants, flavors and one or more sugar(s) that match sugar metabolism profiles of the at least one probiotic strain.